Departamento de Cardiología, Área del Corazón, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain; Instituto de Investigación del Principado de Asturias, Oviedo, Asturias, Spain; Facultad de Medicina, Universidad de Oviedo, Asturias, Spain.
Instituto de Investigación del Principado de Asturias, Oviedo, Asturias, Spain; Departamento de Cirugía Cardiaca, Área del Corazón, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.
Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):822-827. doi: 10.1016/j.rec.2019.10.027. Epub 2020 Mar 5.
Severe symptomatic aortic stenosis carries a very poor prognosis. Transcatheter aortic valve replacement has been demonstrated to change the natural history of the disease. However, it is not known whether the probability of survival in older patients receiving this treatment returns to a similar value to that in the general population. Our objective was to determine survival in these patients vs that in the general population.
We retrospectively analyzed the survival curves of patients older than 75 years who underwent transcatheter aortic valve implantation (TAVI) at our hospital and compared them with those in the general population of the same age, sex, and geographic region by using data from the Spanish National Institute of Statistics.
We analyzed 526 patients. Among postoperative survivors, survival curves were similar between the 2 groups during most of the follow-up. In TAVI patients, the probability of survival at 1, 3, 5, and 8 years of follow-up was 90.58% (confidence interval [CI] 95%, 87.54-92.91), 72.51% (95%CI, 67.38-76.97), 53.23% (95%CI, 46.52-59.48), and 35.73% (95%CI, 27.72-43.80). In the reference population, these percentages were 91.93%, 75.63%, 59.6%, and 37.47%.
Long-term survival in elderly patients undergoing TAVI is influenced by postoperative mortality. In patients surviving the postoperative period, the probability of survival returns to a similar value to that in the general population of the same age, sex, and geographical area.
严重症状性主动脉瓣狭窄预后极差。经导管主动脉瓣置换术已经证明可以改变疾病的自然病程。然而,尚不清楚接受这种治疗的老年患者的生存概率是否会恢复到与普通人群相似的值。我们的目的是确定这些患者的生存率与普通人群相比如何。
我们回顾性分析了在我院接受经导管主动脉瓣植入术(TAVI)的年龄大于 75 岁的患者的生存曲线,并与同一年龄、性别和地理区域的普通人群进行比较,使用西班牙国家统计局的数据。
我们分析了 526 名患者。在术后幸存者中,两组在大多数随访期间的生存曲线相似。在 TAVI 患者中,1、3、5 和 8 年随访的生存率分别为 90.58%(95%置信区间 [CI],87.54-92.91)、72.51%(95%CI,67.38-76.97)、53.23%(95%CI,46.52-59.48)和 35.73%(95%CI,27.72-43.80)。在参考人群中,这些百分比分别为 91.93%、75.63%、59.6%和 37.47%。
接受 TAVI 的老年患者的长期生存率受到术后死亡率的影响。在术后存活的患者中,生存概率恢复到与同一年龄、性别和地理区域的普通人群相似的值。